These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 18157589)

  • 1. [Bronchial carcinoma--light on the horizon!].
    Hilbe W
    Wien Med Wochenschr; 2007; 157(21-22):535. PubMed ID: 18157589
    [No Abstract]   [Full Text] [Related]  

  • 2. [After care in bronchial carcinoma. Results of postoperative polychemotherapy].
    Karrer K; Pridun N; Denck H
    Fortschr Med; 1976 Mar; 94(7):379-85. PubMed ID: 184021
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemotherapeutic studies in bronchogenic carcinoma by the Austrian study group.
    Karrer K; Pridun N; Zwintz E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):207-13. PubMed ID: 4729324
    [No Abstract]   [Full Text] [Related]  

  • 4. [Does chemotherapy bring real benefit to patients with inoperable bronchial epidermoid cancer?].
    Depierre A
    Rev Mal Respir; 1986; 3(4):169-71. PubMed ID: 3786923
    [No Abstract]   [Full Text] [Related]  

  • 5. [Investigation on the complications in bronchial artery infusion with chemotherapeutic agent to treat bronchogenic carcinoma].
    Qian MS
    Zhonghua Fang She Xue Za Zhi; 1989 Jun; 23(3):143-5. PubMed ID: 2582903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor drugs in inoperable lung cancer.
    Behera D; Malik SK
    Indian J Chest Dis Allied Sci; 1984; 26(1):60-1. PubMed ID: 6510992
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bronchial arterial infusion therapy for inoperable bronchogenic carcinoma (author's transl)].
    Ogawa J; Ishihara T; Kikuchi K; Inoue H; Fukai S
    Kyobu Geka; 1977; 30(8):640-5. PubMed ID: 904116
    [No Abstract]   [Full Text] [Related]  

  • 8. Selecting appropriate therapy for bronchial carcinoma.
    Shields TW
    Geriatrics; 1974 Jul; 29(7):54-60. PubMed ID: 4835739
    [No Abstract]   [Full Text] [Related]  

  • 9. [Spirazidin in the complex treatment of lung cancer].
    Shkrob OS; Zharikov AA
    Khirurgiia (Mosk); 1970 Aug; 46(8):17-22. PubMed ID: 5473666
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II evaluation of mitoxantrone in patients with bronchogenic carcinoma: a Southeastern Cancer Study Group trial.
    Kramer BS; Gams R; Birch R; Einhorn L; Buchanan R
    Cancer Treat Rep; 1984 Oct; 68(10):1295-6. PubMed ID: 6525601
    [No Abstract]   [Full Text] [Related]  

  • 11. Preliminary observations on the Ledakrin effects in treatment of patients with lung carcinoma.
    Kwasniewska-Rokicińska C; Swiecki J; Drosik K
    Mater Med Pol; 1976; 8(3):289-94. PubMed ID: 1011871
    [No Abstract]   [Full Text] [Related]  

  • 12. [Status of chemotherapy in inoperable non-small cell bronchial carcinoma].
    Brunner KW; Joss R; Goldhirsch A
    Schweiz Rundsch Med Prax; 1983 Aug; 72(32):1057-62. PubMed ID: 6622423
    [No Abstract]   [Full Text] [Related]  

  • 13. Radicality of surgery after inductive chemotherapy of bronchogenic cancer.
    Novák K; Pesek M; Tauchman A; Bürger J; Chudácek Z
    Acta Univ Palacki Olomuc Fac Med; 2000; 143():98-9. PubMed ID: 11144147
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II clinical trial of diaziquone in bronchogenic carcinoma.
    Chiuten DF; Umsawasdi T; Dhingra HM; Murphy WK; Spitzer G; Carr DT; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1985; 69(7-8):921-2. PubMed ID: 4016800
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cytostatic therapy of bronchial carcinoma].
    Dold U
    Minerva Med; 1973 Oct; 64(76):3988-90. PubMed ID: 4357942
    [No Abstract]   [Full Text] [Related]  

  • 16. New agents and combinations in the treatment of bronchogenic carcinoma.
    Bodey GP; Gottlieb JA; Livingston R; Frei E
    Cancer Chemother Rep 3; 1973 Mar; 4(2):227-9. PubMed ID: 4125740
    [No Abstract]   [Full Text] [Related]  

  • 17. [After care of operated bronchogenic carcinoma with an atoxic antineoplastic agent].
    Hansen JL
    Ugeskr Laeger; 1975 Jun; 137(26):1466-9. PubMed ID: 1096394
    [No Abstract]   [Full Text] [Related]  

  • 18. Bronchogenic carcinoma: new drugs available for study.
    Slavik M; Carter SK
    Cancer Chemother Rep 3; 1973 Mar; 4(2):265-9. PubMed ID: 4125744
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of a combination of cytostatics with substances influencing neuro-humoral regulation (K6) in the treatment of lung cancer.
    Jelínek V; Petríková J; Zlatkovská E; Rezábek K
    Neoplasma; 1971; 18(5):481-4. PubMed ID: 4399163
    [No Abstract]   [Full Text] [Related]  

  • 20. Panel report. Interdisciplinary group on clinical trials (biostatistics).
    Zelen M
    Cancer Chemother Rep 3; 1973 Mar; 4(2):317-9. PubMed ID: 4580859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.